188 related articles for article (PubMed ID: 7488312)
21. Biological activities of novel thienothiazine derivatives on heart and smooth muscle preparations of guinea pigs.
Studenik C; Lemmens-Gruber R; Heistracher P
Arzneimittelforschung; 1999 Sep; 49(9):740-4. PubMed ID: 10514900
[TBL] [Abstract][Full Text] [Related]
22. The new generation dihydropyridine type calcium blockers, bearing 4-phenyl oxypropanolamine, display alpha-/beta-adrenoceptor antagonist and long-acting antihypertensive activities.
Liang JC; Yeh JL; Wang CS; Liou SF; Tsai CH; Chen IJ
Bioorg Med Chem; 2002 Mar; 10(3):719-30. PubMed ID: 11814861
[TBL] [Abstract][Full Text] [Related]
23. Synthesis of some 1,4-dihydropyridine derivatives and their calcium antagonistic activity.
Safak C; Sahin I; Sunal R
Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):119-22. PubMed ID: 2334450
[TBL] [Abstract][Full Text] [Related]
24. PN 200-110, a new calcium antagonist: electrophysiological, inotropic, and chronotropic effects on guinea pig myocardial tissue and effects on contraction and calcium uptake of rabbit aorta.
Hof RP; Scholtysik G; Loutzenhiser R; Vuorela HJ; Neumann P
J Cardiovasc Pharmacol; 1984; 6(3):399-406. PubMed ID: 6202964
[TBL] [Abstract][Full Text] [Related]
25. Long acting dihydropyridine calcium antagonists. 2. 2-[2-Aminoheterocycloethoxy]methyl derivatives.
Arrowsmith JE; Campbell SF; Cross PE; Burges RA; Gardiner DG
J Med Chem; 1989 Mar; 32(3):562-8. PubMed ID: 2918502
[TBL] [Abstract][Full Text] [Related]
26. Cardiovascular characterization of pyrrolo[2,1-d][1,5]benzothiazepine derivatives binding selectively to the peripheral-type benzodiazepine receptor (PBR): from dual PBR affinity and calcium antagonist activity to novel and selective calcium entry blockers.
Campiani G; Fiorini I; De Filippis MP; Ciani SM; Garofalo A; Nacci V; Giorgi G; Sega A; Botta M; Chiarini A; Budriesi R; Bruni G; Romeo MR; Manzoni C; Mennini T
J Med Chem; 1996 Jul; 39(15):2922-38. PubMed ID: 8709127
[TBL] [Abstract][Full Text] [Related]
27. Negative inotropic and calcium antagonistic activity of alkyl and arylalkyl phosphonates.
Bellucci C; Gualtieri F; Scapecchi S; Teodori E; Budriesi R; Chiarini A
Farmaco; 1989 Dec; 44(12):1167-91. PubMed ID: 2634406
[TBL] [Abstract][Full Text] [Related]
28. Calcium channel blocking and positive inotropic activities of ethyl 5-cyano-1,4-dihydro-6-methyl-2-[(phenylsulfonyl)methyl]-4-aryl-3- pyridine-carboxylate and analogues. Synthesis and structure-activity relationships.
Sircar I; Gregor EK; Anderson KR; Haleen SJ; Shih YH; Weishaar RE; Steffen RP; Pugsley TA; Taylor MD
J Med Chem; 1991 Jul; 34(7):2248-60. PubMed ID: 2066997
[TBL] [Abstract][Full Text] [Related]
29. Long-acting dihydropyridine calcium antagonists. 4. Synthesis and structure-activity relationships for a series of basic and nonbasic derivatives of 2-[(2-aminoethoxy)methyl]-1,4-dihydropyridine calcium antagonists.
Alker D; Campbell SF; Cross PE; Burges RA; Carter AJ; Gardiner DG
J Med Chem; 1990 Feb; 33(2):585-91. PubMed ID: 2153819
[TBL] [Abstract][Full Text] [Related]
30. Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine.
Guarneri L; Angelico P; Ibba M; Poggesi E; Taddei C; Leonardi A; Testa R
Arzneimittelforschung; 1996 Jan; 46(1):15-24. PubMed ID: 8821512
[TBL] [Abstract][Full Text] [Related]
31. Cardiovascular selectivity of 1,4-dihydropyridine derivatives, efonidipine (NZ-105), nicardipine and structure related compounds in isolated guinea-pig tissues.
Masuda Y; Miyajima M; Shudo C; Tanaka S; Shigenobu K; Kasuya Y
Gen Pharmacol; 1995 Mar; 26(2):339-45. PubMed ID: 7590084
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and biological properties of RWJ 22108, a bronchoselective calcium channel blocker.
Dodd JH; Schwender CF; Conley RA; Moore JB; Ritchie DM; Fabian AC; Fenk CJ; Bourcet E; Gray-Nunez Y; Kirchner T
Drug Des Discov; 1993; 10(1):65-75. PubMed ID: 8399994
[No Abstract] [Full Text] [Related]
33. Synthesis and cardiovascular properties of fluorenyl derivatives related to verapamil.
Romanelli MN; Teodori E; Scapecchi S; Dei S; Budriesi R; Chiarini A
Farmaco; 1991 Oct; 46(10):1121-38. PubMed ID: 1815578
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and calcium channel antagonist activity of new 1,4-dihydropyridine derivatives containing dichloroimidazolyl substituents.
Amini M; Golabchifar AA; Dehpour AR; Pirali HM; Shafiee A
Arzneimittelforschung; 2002; 52(1):21-6. PubMed ID: 11838270
[TBL] [Abstract][Full Text] [Related]
35. In vitro effects of the new calcium antagonist lacidipine.
Kawada T; Sun HT; Nakazawa M; Imai S
Jpn J Pharmacol; 1993 Jul; 62(3):289-96. PubMed ID: 8411776
[TBL] [Abstract][Full Text] [Related]
36. Cardiac and vascular effects of NZ-105, a novel dihydropyridine derivative, in vitro.
Masuda Y; Iwama T; Yamashita T; Sakai T; Hibi M; Tanaka S; Shigenobu K; Kasuya Y
Arch Int Pharmacodyn Ther; 1991; 314():57-73. PubMed ID: 1668604
[TBL] [Abstract][Full Text] [Related]
37. Synthesis, QSAR and calcium channel antagonist activity of new 1,4-dihydropyridine derivatives containing 1-methyl-4,5-dichloroimidazolyl substituents.
Hosseini M; Miri R; Amini M; Mirkhani H; Hemmateenejad B; Ghodsi S; Alipour E; Shafiee A
Arch Pharm (Weinheim); 2007 Oct; 340(10):549-56. PubMed ID: 17849444
[TBL] [Abstract][Full Text] [Related]
38. Cardiotonic agents. 1. Synthesis and structure-activity relationships in a new class of 3-, 4-, and 5-pyridyl-2(1H)-quinolone derivatives.
Leclerc G; Marciniak G; Decker N; Schwartz J
J Med Chem; 1986 Dec; 29(12):2427-32. PubMed ID: 3783603
[TBL] [Abstract][Full Text] [Related]
39. Enantioselective syntheses and calcium channel modulating effects of (+)- and (-)-3-isopropyl 5-(4-methylphenethyll) 1,4-dihydro-2,6-dimethyl-4-(2-pyridyl)-3,5-pyridinedicarboxylates.
Iqbal N; Vo D; McEwen CA; Wolowyk MW; Knaus EE
Chirality; 1994; 6(7):515-20. PubMed ID: 7986665
[TBL] [Abstract][Full Text] [Related]
40. Antihypertensive and cardiovascular effects of the new dihydropyridine derivative methyl (E)-3-phenyl-2-propen-1-yl-1,4-dihydro-2,6-dimethyl- 4-(3-nitrophenyl)pyridine-3,5-dicarboxylate.
Yamaura T; Kase N; Kita H; Uematsu T
Arzneimittelforschung; 1986; 36(1):29-34. PubMed ID: 3754142
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
